- Corporate Officers - S
- Shah Nimish P
Insider Trading History of Shah Nimish P
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Shah Nimish P since 2018.
This trader's CIK number is 1698082.
At the time of last reporting, Shah Nimish P was the Officer of Kalvista Pharmaceuticals, Inc.. (stock ticker symbol KALV).
Also see all insider trading activities at Kalvista Pharmaceuticals, Inc..
Note that in the past
Shah Nimish P also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Constellation Pharmaceuticals Inc (CNST) by Shah Nimish P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | CNST | 400,000 | $13,800,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kalvista Pharmaceuticals, Inc. (KALV) by Shah Nimish P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | KALV | 361,212 | $3,322,932 | 0 | $0 | 0 | $0 |
| 2024 | KALV | 732,000 | $9,646,480 | 0 | $0 | 0 | $0 |
| 2023 | KALV | 519,017 | $6,465,649 | 0 | $0 | 0 | $0 |
| 2019 | KALV | 0 | $0 | 500,000 | $14,375,000 | 0 | $0 |
Yearly summary of insider trading at Tricida, Inc. (TCDA) by Shah Nimish P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | TCDA | 4,005,768 | $40,324,868 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cogent Biosciences, Inc. (UMRX) by Shah Nimish P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | UMRX | 451,000 | $1,137,119 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Oruka Therapeutics, Inc. (ORKA) by Shah Nimish P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ORKA | 122,882 | $1,407,366 | 0 | $0 | 0 | $0 |
| 2018 | ORKA | 0 | $0 | 1,541,331 | $846,905 | 0 | $0 |
Yearly summary of insider trading at Altimmune, Inc. (ALT) by Shah Nimish P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | ALT | 2,803,636 | $22,534,155 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Vistagen Therapeutics, Inc. (VTGN) by Shah Nimish P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | VTGN | 0 | $0 | 60,000 | $53,400 | 0 | $0 |
Yearly summary of insider trading at Apogee Therapeutics, Inc. (APGE) by Shah Nimish P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | APGE | 1,750,000 | $29,750,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Bellerophon Therapeutics, Inc. (BLPH) by Shah Nimish P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | BLPH | 1,164,370 | $1,039,576 | 0 | $0 | 0 | $0 |
Insider trading activities at 9 companies by Shah Nimish P:
1. Constellation Pharmaceuticals Inc (CNST)
2. Kalvista Pharmaceuticals, Inc. (KALV)
3. Tricida, Inc. (TCDA)
4. Cogent Biosciences, Inc. (UMRX)
5. Oruka Therapeutics, Inc. (ORKA)
6. Altimmune, Inc. (ALT)
7. Vistagen Therapeutics, Inc. (VTGN)
8. Apogee Therapeutics, Inc. (APGE)
9. Bellerophon Therapeutics, Inc. (BLPH)
Table 1. Insider trading of Constellation Pharmaceuticals Inc (CNST) by Shah Nimish P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-12-13 | CNST | Buy | 400,000 | 34.50 | 13,800,000 |
Table 2. Insider trading of Kalvista Pharmaceuticals, Inc. (KALV) by Shah Nimish P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-04-09 | KALV | Buy | 25,000 | 9.42 | 235,500 |
| 2025-02-12 | KALV | Buy | 100,000 | 9.23 | 923,000 |
| 2025-02-13 | KALV | Buy | 61,700 | 9.33 | 575,661 |
| 2025-02-07 | KALV | Buy | 73,649 | 9.29 | 684,199 |
| 2025-02-10 | KALV | Buy | 4,137 | 9.14 | 37,812 |
| 2025-02-11 | KALV | Buy | 26,703 | 9.18 | 245,133 |
| 2025-01-30 | KALV | Buy | 43,707 | 8.76 | 382,873 |
| 2025-01-31 | KALV | Buy | 11,754 | 8.89 | 104,493 |
| 2025-02-03 | KALV | Buy | 14,562 | 9.22 | 134,261 |
| 2024-02-08 | KALV | Buy | 29,747 | 14.70 | 437,280 |
| 2024-02-07 | KALV | Buy | 51,827 | 14.56 | 754,601 |
| 2024-02-06 | KALV | Buy | 4,474 | 14.74 | 65,946 |
| 2024-01-30 | KALV | Buy | 88,099 | 14.47 | 1,274,792 |
| 2024-01-29 | KALV | Buy | 80,600 | 14.22 | 1,146,132 |
| 2024-01-25 | KALV | Buy | 7,030 | 12.73 | 89,491 |
| 2024-01-26 | KALV | Buy | 4,174 | 12.98 | 54,178 |
| 2024-01-22 | KALV | Buy | 67,546 | 12.55 | 847,702 |
| 2024-01-23 | KALV | Buy | 10,897 | 12.54 | 136,648 |
| 2024-01-24 | KALV | Buy | 20,686 | 12.44 | 257,333 |
| 2024-01-19 | KALV | Buy | 25,000 | 12.43 | 310,750 |
| 2024-01-18 | KALV | Buy | 39,680 | 12.51 | 496,396 |
| 2024-01-17 | KALV | Buy | 78,925 | 12.60 | 994,455 |
| 2024-01-16 | KALV | Buy | 19,599 | 12.73 | 249,495 |
| 2024-01-11 | KALV | Buy | 6,647 | 12.68 | 84,283 |
| 2024-01-08 | KALV | Buy | 69,184 | 12.44 | 860,648 |
| 2024-01-09 | KALV | Buy | 20,816 | 12.56 | 261,448 |
| 2024-01-10 | KALV | Buy | 47,700 | 12.67 | 604,359 |
| 2024-01-04 | KALV | Buy | 41,764 | 12.11 | 505,762 |
| 2024-01-03 | KALV | Buy | 17,605 | 12.20 | 214,781 |
| 2023-12-28 | KALV | Buy | 471,490 | 12.50 | 5,893,625 |
| 2023-12-29 | KALV | Buy | 6,013 | 12.49 | 75,102 |
| 2023-12-27 | KALV | Buy | 41,514 | 11.97 | 496,922 |
| 2019-03-18 | KALV | Sale | 500,000 | 28.75 | 14,375,000 |
Table 3. Insider trading of Tricida, Inc. (TCDA) by Shah Nimish P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-10-19 | TCDA | Buy | 311,466 | 10.77 | 3,354,488 |
| 2022-10-18 | TCDA | Buy | 40,400 | 11.98 | 483,992 |
| 2022-10-13 | TCDA | Buy | 4,674 | 11.98 | 55,994 |
| 2022-10-17 | TCDA | Buy | 170,292 | 11.67 | 1,987,307 |
| 2022-10-11 | TCDA | Buy | 25,000 | 11.85 | 296,250 |
| 2022-10-10 | TCDA | Buy | 80,314 | 11.89 | 954,933 |
| 2022-10-07 | TCDA | Buy | 28,900 | 12.00 | 346,800 |
| 2022-10-03 | TCDA | Buy | 268,736 | 11.27 | 3,028,654 |
| 2022-09-29 | TCDA | Buy | 168,187 | 9.92 | 1,668,415 |
| 2022-10-03 | TCDA | Buy | 268,736 | 11.27 | 3,028,654 |
| 2022-09-29 | TCDA | Buy | 168,187 | 9.92 | 1,668,415 |
| 2022-09-26 | TCDA | Buy | 395,614 | 8.56 | 3,386,455 |
| 2022-09-27 | TCDA | Buy | 115,000 | 9.38 | 1,078,700 |
| 2022-09-28 | TCDA | Buy | 76,600 | 9.92 | 759,872 |
| 2022-07-29 | TCDA | Buy | 18,900 | 9.21 | 174,069 |
| 2022-07-25 | TCDA | Buy | 29,199 | 8.95 | 261,331 |
| 2022-07-21 | TCDA | Buy | 30,000 | 9.59 | 287,700 |
| 2022-07-22 | TCDA | Buy | 15,000 | 9.21 | 138,150 |
| 2022-07-20 | TCDA | Buy | 25,000 | 9.54 | 238,499 |
| 2022-07-19 | TCDA | Buy | 25,000 | 9.47 | 236,750 |
| 2022-07-18 | TCDA | Buy | 100,000 | 9.02 | 902,000 |
| 2022-07-13 | TCDA | Buy | 32,856 | 9.98 | 327,902 |
| 2022-07-14 | TCDA | Buy | 36,717 | 9.85 | 361,662 |
| 2022-07-12 | TCDA | Buy | 25,000 | 9.81 | 245,250 |
| 2022-07-01 | TCDA | Buy | 55,700 | 9.65 | 537,505 |
| 2022-07-05 | TCDA | Buy | 32,500 | 9.53 | 309,725 |
| 2022-06-30 | TCDA | Buy | 11,958 | 9.66 | 115,514 |
| 2022-06-29 | TCDA | Buy | 16,546 | 9.93 | 164,301 |
| 2022-06-28 | TCDA | Buy | 34,366 | 9.71 | 333,693 |
| 2022-06-22 | TCDA | Buy | 142,900 | 10.90 | 1,557,610 |
| 2022-06-23 | TCDA | Buy | 200,000 | 10.50 | 2,100,000 |
| 2022-06-24 | TCDA | Buy | 149,120 | 9.68 | 1,443,481 |
| 2022-06-16 | TCDA | Buy | 5,951 | 9.69 | 57,665 |
| 2022-06-14 | TCDA | Buy | 10,000 | 8.72 | 87,200 |
| 2022-06-13 | TCDA | Buy | 50,000 | 8.14 | 407,000 |
| 2022-06-10 | TCDA | Buy | 58,054 | 8.91 | 517,261 |
| 2022-06-07 | TCDA | Buy | 367,813 | 9.89 | 3,637,670 |
| 2022-06-08 | TCDA | Buy | 111,111 | 9.51 | 1,056,665 |
| 2022-06-09 | TCDA | Buy | 109,100 | 8.97 | 978,627 |
| 2022-06-06 | TCDA | Buy | 91,506 | 9.35 | 855,581 |
| 2022-06-02 | TCDA | Buy | 61,722 | 8.78 | 541,919 |
| 2022-06-03 | TCDA | Buy | 37,643 | 9.33 | 351,209 |
Table 4. Insider trading of Cogent Biosciences, Inc. (UMRX) by Shah Nimish P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-08-14 | UMRX | Buy | 100,000 | 2.30 | 229,999 |
| 2020-08-18 | UMRX | Buy | 101,000 | 2.62 | 264,620 |
| 2020-08-17 | UMRX | Buy | 250,000 | 2.57 | 642,500 |
Table 5. Insider trading of Oruka Therapeutics, Inc. (ORKA) by Shah Nimish P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-10 | ORKA | Buy | 574 | 10.90 | 6,256 |
| 2025-02-11 | ORKA | Buy | 9,593 | 10.95 | 105,043 |
| 2025-02-12 | ORKA | Buy | 8,971 | 11.86 | 106,396 |
| 2025-02-13 | ORKA | Buy | 14,950 | 11.63 | 173,868 |
| 2025-02-14 | ORKA | Buy | 88,794 | 11.44 | 1,015,803 |
| 2018-02-26 | ABIO | Sale | 1,500,000 | .55 | 825,000 |
| 2018-02-27 | ABIO | Sale | 41,331 | .53 | 21,905 |
Table 6. Insider trading of Altimmune, Inc. (ALT) by Shah Nimish P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-06-15 | ALT | Buy | 1,500,000 | 7.54 | 11,310,000 |
| 2020-05-27 | ALT | Buy | 402,162 | 7.58 | 3,046,377 |
| 2020-05-28 | ALT | Buy | 201,474 | 8.33 | 1,678,278 |
| 2020-05-26 | ALT | Buy | 700,000 | 9.29 | 6,499,500 |
Table 7. Insider trading of Vistagen Therapeutics, Inc. (VTGN) by Shah Nimish P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-07-12 | VTGN | Sale | 60,000 | .89 | 53,400 |
Table 8. Insider trading of Apogee Therapeutics, Inc. (APGE) by Shah Nimish P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-07-13 | APGE | Buy | 1,750,000 | 17.00 | 29,750,000 |
Table 9. Insider trading of Bellerophon Therapeutics, Inc. (BLPH) by Shah Nimish P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-09-10 | BLPH | Buy | 200,000 | 1.22 | 243,600 |
| 2018-09-12 | BLPH | Buy | 75,000 | 1.15 | 85,950 |
| 2018-09-11 | BLPH | Buy | 200,000 | 1.14 | 228,799 |
| 2018-09-07 | BLPH | Buy | 60,000 | .90 | 53,760 |
| 2018-09-05 | BLPH | Buy | 50,000 | .85 | 42,350 |
| 2018-09-06 | BLPH | Buy | 50,000 | .84 | 42,100 |
| 2018-08-14 | BLPH | Buy | 190,977 | .65 | 123,944 |
| 2018-08-15 | BLPH | Buy | 272,000 | .65 | 175,984 |
| 2018-08-16 | BLPH | Buy | 66,393 | .65 | 43,089 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Shah Nimish P
(Officer of Kalvista Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.